Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1989 2
1992 1
1993 2
1998 1
1999 2
2001 3
2002 3
2003 2
2004 5
2005 7
2006 15
2007 4
2008 7
2009 3
2010 10
2011 13
2012 19
2013 12
2014 10
2015 11
2016 11
2017 7
2018 19
2019 21
2020 26
2021 36
2022 22
2023 13
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

265 results

Results by year

Filters applied: . Clear all
Page 1
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial.
Qin S, Chen M, Cheng AL, Kaseb AO, Kudo M, Lee HC, Yopp AC, Zhou J, Wang L, Wen X, Heo J, Tak WY, Nakamura S, Numata K, Uguen T, Hsiehchen D, Cha E, Hack SP, Lian Q, Ma N, Spahn JH, Wang Y, Wu C, Chow PKH; IMbrave050 investigators. Qin S, et al. Lancet. 2023 Nov 18;402(10415):1835-1847. doi: 10.1016/S0140-6736(23)01796-8. Epub 2023 Oct 20. Lancet. 2023. PMID: 37871608 Clinical Trial.
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study.
Qin S, Chan SL, Gu S, Bai Y, Ren Z, Lin X, Chen Z, Jia W, Jin Y, Guo Y, Hu X, Meng Z, Liang J, Cheng Y, Xiong J, Ren H, Yang F, Li W, Chen Y, Zeng Y, Sultanbaev A, Pazgan-Simon M, Pisetska M, Melisi D, Ponomarenko D, Osypchuk Y, Sinielnikov I, Yang TS, Liang X, Chen C, Wang L, Cheng AL, Kaseb A, Vogel A; CARES-310 Study Group. Qin S, et al. Lancet. 2023 Sep 30;402(10408):1133-1146. doi: 10.1016/S0140-6736(23)00961-3. Epub 2023 Jul 24. Lancet. 2023. PMID: 37499670 Clinical Trial.
A second cryoballoon system-New and improved?
Su WW. Su WW. J Cardiovasc Electrophysiol. 2021 Apr;32(4):931-932. doi: 10.1111/jce.14953. Epub 2021 Mar 4. J Cardiovasc Electrophysiol. 2021. PMID: 33590586
Cryoballoon ablation for extrapulmonary vein targets.
Ling TY, Chen L, Su WW, Wu LQ. Ling TY, et al. Among authors: su ww. Curr Opin Cardiol. 2021 Jan;36(1):22-25. doi: 10.1097/HCO.0000000000000802. Curr Opin Cardiol. 2021. PMID: 33027099 Review.
Non-viral 2A-like sequences for protein coexpression.
Su WW, Zhang B, Han Z, Kumar S, Gupta M. Su WW, et al. J Biotechnol. 2022 Nov 10;358:1-8. doi: 10.1016/j.jbiotec.2022.08.014. Epub 2022 Aug 20. J Biotechnol. 2022. PMID: 35995093
265 results